Protein concentration (mg/ml) | Triazolam | Diazepam | Clonazepam | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CLint | fu | CLint (u) | CLint | fu | CLint (u) | CLint | fu | CLint (u) | |||||||
0.1 | 230 ± 80 | 0.98 | 240 ± 81 | ||||||||||||
0.5 | 230 ± 35 | 0.91 | 250 ± 38 | 210 ± 60 | 0.93 | 250 ± 72 | 81 ± 7.9 | 0.86 | 94 ± 9.1a | ||||||
1 | 190 ± 25 | 0.84 | 230 ± 30 | 0.88 | 74 ± 7.4 | 0.76 | 97 ± 9.7a | ||||||||
2 | 160 ± 26 | 0.72 | 220 ± 35a | 0.78 | 52 ± 5.5 | 0.61 | 86 ± 9.0a,b | ||||||||
5 | 93 ± 20 | 0.51 | 180 ± 40a,b | 73 ± 23 | 0.58 | 210 ± 67a,b | 23 ± 2.6 | 0.38 | 61 ± 6.8a,b |
↵ a The biexponential model gave the best model fit (according to the AIC); however, only the monoexponential estimate is shown (where the 1/y weighting resulted in emphasis on the first phase of the profile. N.B.: Use of only the initial phase in the fitting had no impact on the CLint prediction).
↵ b Significantly different from the lowest microsomal protein concentration for unbound CLint values only (p < 0.05, Dunnett's test for triazolam and clonazepam and two-way ANOVA for diazepam).